PubMed COVID-19 Clinical Care
56281 - 56290 of 57753 results found
Critical Stepwise Decline of Antibodies against SARS-CoV-2 among Chronic Hemodialysis Patients 180 Days Post Comirnaty Vaccine
Description
CONCLUSIONS: We recommend all patients on hemodialysis receive a booster COVID-19 vaccine 6 months after the second dose.
COVID-19 and Mucormycosis in India a Study on Implicated Risk Factors
Description
No abstract
Finite element modeling of alpha-helices and tropocollagen molecules with reference to the spike of SARS-CoV-2
Description
The newly developed finite element modeling at the atomic scale was used to predict the static and dynamic response of the alpha-helix (AH) and tropocollagen (TC) protein fragments, the main building blocks of the spike of the SARS-CoV-2. The
Trends in Pediatric Ophthalmic Emergency Department Visits during the COVID-19 Pandemic
Description
CONCLUSIONS: Parents need to learn appropriate preventive and treatment measures to prevent serious and long-term ophthalmic injury while minimizing their exposure to the COVID-19. PEDs and ophthalmic pediatric clinics should consider increasing use
Covid-19 Induced Myopathy and Encephalopathy in the Same Patient
Description
No abstract
Symptoms and signs of long COVID: A rapid review and meta-analysis
Description
CONCLUSIONS: We have summarised evidence from longitudinal cohort studies on the most common symptoms and signs associated with long COVID. High heterogeneity seen in the meta-analysis means pooled incidence estimates should be interpreted with
Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2
Description
Flavonoids are phenolic compounds naturally found in plants and commonly consumed in diets. Herein, flavonoids were sequentially evaluated by a comparative in silico study associated with systematic literature search. This was followed by an in vitro
Patient Preference for Virtual Versus In-Person Visits in Neuromuscular Clinical Practice
Description
INTRODUCTION/AIMS: It is unknown if patients with neuromuscular diseases prefer in-person or virtual telemedicine visits. We studied patient opinions and preference on virtual versus in-person visits, and the factors influencing such preferences.
